Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „compared“
Suchtreffer
Begriffe & Kennungen
Ocrevus · 4.8 · In RMS, a decrease in lymphocyte < LLN was observed in 20.7% of patients treated with ocrelizumab compared wit
Eintrag öffnenOcrevus · 4.8 · No decreased neutrophil counts were observed in ocrelizumab-treated patients, compared with 3.3% in fingolimod
Eintrag öffnenOcrevus · 4.8 · The proportion of respiratory tract infections was higher in intravenous ocrelizumab treated patients compared
Eintrag öffnenOcrevus · 4.8 · The proportion of respiratory tract infections was higher in ocrelizumab treated patients compared to interfer
Eintrag öffnenOnglyza · 4.8 · Hospitalisation for heart failure, occurred at a greater rate in the saxagliptin group (3.5%) compared with th
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · In NAPOLI-1, compared to Caucasians, Asian patients were observed with a lower incidence of diarrhoea [14 (19.
Eintrag öffnenOrencia · 4.8 · 10 and 1.61 (95% CI 1.29-1.99) in abatacept-treated patients when compared to biological/targeted DMARD-treate
Eintrag öffnenOrencia · 4.8 · Immunogenicity in adults treated with subcutaneous abatacept Study SC-I compared the immunogenicity to abatace
Eintrag öffnenOrencia · 4.8 · Immunogenicity in adults treated with subcutaneous abatacept Study SC-I compared the immunogenicity to abatace
Eintrag öffnenOrencia · 4.8 · Injection Reactions in adult patients treated with subcutaneous abatacept Study SC-I compared the safety of ab
Eintrag öffnenOrencia · 4.8 · Injection Reactions in adult patients treated with subcutaneous abatacept Study SC-I compared the safety of ab
Eintrag öffnenOsenvelt · 4.8 · A higher incidence of ONJ among patients treated with denosumab compared to zoledronic acid has been observed
Eintrag öffnenOsenvelt · 4.8 · Hypocalcaemia A higher incidence of hypocalcaemia among patients treated with denosumab compared to zoledronic
Eintrag öffnenPhesgo · 4.8 · 18 neoadjuvant pertuzumab, trastuzumab and docetaxel experienced febrile neutropenia compared with 4 % of Asia
Eintrag öffnenPonvory · 4.8 · Blood lymphocyte count reduction In OPTIMUM, 3.2% of ponesimod-treated patients compared to none of the patien
Eintrag öffnenPonvory · 4.8 · Macular oedema In OPTIMUM, macular oedema was reported in 1.1% of ponesimod-treated patients compared to none
Eintrag öffnenPrevenar 13 · 4.5 · When Prevenar 13 was given concomitantly with TIV, the immune responses to Prevenar 13 were lower compared to
Eintrag öffnenPrevenar 13 · 4.5 · When Prevenar 13 was given concomitantly with TIV, the immune responses to Prevenar 13 were lower compared to
Eintrag öffnenPrevenar 13 · 4.5 · When Prevenar 13 was given concomitantly with TIV, the immune responses to Prevenar 13 were lower compared to
Eintrag öffnenPrevenar 13 · 4.8 · An increase in vaccination-site reactions was reported in children older than 12 months compared to rates obse
Eintrag öffnen